CS logo
small CS logo
Clinica Ematologica - Policlinico Universitario

Udine, Italy
Ospedale universitario a Udine

About Clinica Ematologica - Policlinico Universitario


L'Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, è una struttura ospedaliera ed universitaria regionale di rilievo nazionale e di alta specializzazione con sede a Udine, è classificata come A.R.N.A.S.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
38
Gruppo Italiano Trapianto di Midollo Osseo
8
Fondazione Italiana Linfomi ONLUS
5
Celgene Corporation
1
Incyte Corporation
1
Northwestern University
1
University of Bologna
1
Total Rows: 7

Clinical Trials at Clinica Ematologica - Policlinico Universitario


During the past decade, Clinica Ematologica - Policlinico Universitario conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years332233774422000000220000Started TrialsCompleted Trails20162017201820192020202102468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
2003-02-01
2013-08-01
Completed
470
Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
2003-03-01
Unknown status
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
2005-03-01
2011-08-01
Completed
121
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
2007-11-01
2020-01-28
Completed
102
Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
2007-06-23
2018-04-30
Completed
74
Phase III Trial in Acute Promyelocytic Leukemia Patients
2007-08-01
2019-10-17
Completed
276
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
2008-04-01
2016-02-01
Completed
150
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
2008-02-01
2016-01-01
Completed
42

Rows per page:

1–55 of 55

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clinica Ematologica - Policlinico Universitario" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 38 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 8 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 5 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Ematologica - Policlinico Universitario" #1 collaborator was "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Augusta University" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria Careggi" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator and "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGruppo Italiano MalattieEMatologichedell'Adulto: 38Gruppo Italiano MalattieEMatologichedell'Adulto: 38Gruppo ItalianoTrapianto di MidolloOsseo: 8Gruppo ItalianoTrapianto di MidolloOsseo: 8Fondazione ItalianaLinfomi ONLUS: 5Fondazione ItalianaLinfomi ONLUS: 5Celgene Corporation: 1Celgene Corporation: 1Incyte Corporation: 1Incyte Corporation: 1Northwestern University: 1Northwestern University: 1University of Bologna: 1University of Bologna: 1

Created with Highcharts 11.1.0Top CollaboratorsAssociazione Italiana diImmunogenetica eBiologia dei Trapianti(AIBT): 1Associazione Italiana diImmunogenetica eBiologia dei Trapianti(AIBT): 1Augusta University: 1Augusta University: 1Azienda Ospedaliero-Universitaria Careggi: 1Azienda Ospedaliero-Universitaria Careggi: 1Azienda Policlinico Umberto I: 1Azienda Policlinico Umberto I: 1Azienda Socio SanitariaTerritoriale degli SpedaliCivili di Brescia: 1Azienda Socio SanitariaTerritoriale degli SpedaliCivili di Brescia: 1ERIC Group: 1ERIC Group: 1Fondazione GIMEMA -Franco Mandelli Onlus:1Fondazione GIMEMA -Franco Mandelli Onlus:1Hematology ProjectFoundation: 1Hematology ProjectFoundation: 1Istituto Clinico Humanitas: 1Istituto Clinico Humanitas: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1

Clinical Trials Conditions at Clinica Ematologica - Policlinico Universitario


According to Clinical.Site data, the most researched conditions in "Clinica Ematologica - Policlinico Universitario" are "Chronic Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Hematologic Diseases" (3 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "Clinica Ematologica - Policlinico Universitario" in a lesser frequency.

Clinical Trials Intervention Types at Clinica Ematologica - Policlinico Universitario


Most popular intervention types in "Clinica Ematologica - Policlinico Universitario" are "Drug" (35 trials), "Other" (8 trials), "Procedure" (4 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nilotinib" (4 trials), "Imatinib" (3 trials), "Lenalidomide" (3 trials), "Cyclophosphamide" (2 trials) and "Eltrombopag" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Clinica Ematologica - Policlinico Universitario


The vast majority of trials in "Clinica Ematologica - Policlinico Universitario" are 54 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Clinica Ematologica - Policlinico Universitario


Currently, there are NaN active trials in "Clinica Ematologica - Policlinico Universitario". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Clinica Ematologica - Policlinico Universitario, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Ematologica - Policlinico Universitario, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 21Phase 2: 21Phase 3: 10Phase 3: 10Not Applicable: 3Not Applicable: 3Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 34Completed: 34Recruiting: 8Recruiting: 8Active, not recruiting: 5Active, not recruiting: 5Terminated: 4Terminated: 4Unknown status: 4Unknown status: 4